PerkinElmer does not endorse or make recommendations with respect to research, medication, or treatments.All
information presented is for informational purposes only and is not intended as medical advice. For country specific
recommendations please consult your local health care professionals.
Products may not be licensed in accordance with their laws in all countries, such as the United States and Canada.
Please check with your local representative for availability.
1. Daniel L. Rolnik et al.Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
DOI: 10.1056/NEJMoa1704559, New England J Med June 2017
Copyright © 2019 PerkinElmer, Inc. All rights reserved. PerkinElmer® is a registered trademark of PerkinElmer.
JOIN OUR MISSION
TO PREVENT
PRE-ECLAMPSIA
High sensitivity
the ASPRE assay
PlGF 1-2-3™ kit
ASPRE is
definitive proof
First trimester screening in combination with
Aspirin, results in a significant 62% reduction
in the incidence of preterm pre-eclampsia
1
.
PlGF 1-2-3™ kit also for 2
nd
and 3
rd
Trimester
pre-eclampsia screening.
aspre.perkinelmer.com
